Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea · Delayed Price · Currency is KRW 14,790
+110 (0.75%)
At close: Feb 20, 2026
KRX:271980 Market Cap
KRX:271980 has a market cap or net worth of 215.51 billion as of February 20, 2026. Its market cap has increased by 27.39% in one year.
Market Cap
215.51B
Enterprise Value
291.55B
Revenue
621.98B
Ranking
n/a
PE Ratio
10.97
Stock Price
14,790.00
Market Cap Chart
Since March 15, 2022, KRX:271980's market cap has decreased from 390.14B to 215.51B, a decrease of -44.76%. That is a compound annual growth rate of -13.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 213.91B | -3.10% |
| Dec 30, 2025 | 220.76B | 32.89% |
| Dec 30, 2024 | 166.12B | -33.33% |
| Dec 28, 2023 | 249.17B | -18.65% |
| Dec 29, 2022 | 306.28B | -21.50% |
| Mar 15, 2022 | 390.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daewon Pharmaceutical | 253.99B |
| Samjin Pharmaceuticals | 240.37B |
| Samil Pharmaceutical Co.,Ltd | 239.68B |
| HLB Pharmaceutical | 234.08B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| AptaBio Therapeutics | 224.75B |
| JW Lifescience | 210.90B |
| REYON Pharmaceutical | 209.09B |